Page
%P
![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Chapter and Conference Paper
High-Dose Ara-C as a Single-Agent Consolidation Therapy in Childhood Acute Myelogenous Leukemia
Acute myelogenous leukemia (AML) represents a difficult and heterogeneous group of leukemias from cells of myeloid origin [6, 8]. In the Nordic countries, all cases of acute childhood leukemias have been regis...